Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis.

Cardiovasc Diabetol · 2020 · PMC7525990 · PMID 32993654

Europe PMC DOI

hedged sentence

0.3070

closest p · 6.1× alpha

0.3070

boldest claim

The sentences

showed a trendp = 0.307not close (p > 0.1)

Compared to placebo, SGLT2i drugs showed a trend towards larger reduction in the risk of MACE among patients with CKD than among patients without CKD [0.82 (0.69–0.97) vs 0.91 (0.83–1.00)], (p = 0.307).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.